OKUMURA; Yoshiyuki
Patent Applications and Registrations
Patent applications and USPTO patent grants for OKUMURA; Yoshiyuki.The latest application filed is for "process for the differential solubility-driven asymmetric transformation of substituted 2h-chromene-3-carboxylic acids".
- OKUMURA; Yoshiyuki - Aichi JP
- OKUMURA; Yoshiyuki - Nagoya-shi JP
- Okumura; Yoshiyuki - Aichi-ken JP
- Okumura; Yoshiyuki - Chita-gun JP
- Okumura; Yoshiyuki - Chita JP
| Patent | Date |
|---|---|
| Process For The Differential Solubility-driven Asymmetric Transformation Of Substituted 2h-chromene-3-carboxylic Acids App 20220144792 - OKUMURA; Yoshiyuki ; et al. | 2022-05-12 |
| Ep4 Inhibitors And Synthesis Thereof App 20210300921 - MANFREDI; Mark ; et al. | 2021-09-30 |
| Salts and crystal forms Grant 9,447,066 - Okumura , et al. September 20, 2 | 2016-09-20 |
| Pharmaceutical composition Grant 9,447,065 - Iwata , et al. September 20, 2 | 2016-09-20 |
| Salts And Crystal Forms App 20150353520 - OKUMURA; Yoshiyuki ; et al. | 2015-12-10 |
| Pharmaceutical Composition App 20140256804 - Iwata; Yasuhiro ; et al. | 2014-09-11 |
| Substituted methyl aryl or heteroaryl amide compounds Grant 8,084,476 - Koike , et al. December 27, 2 | 2011-12-27 |
| Substituted Methyl Aryl or Heteroaryl Amide Compounds App 20090163558 - Koike; Hiroki ; et al. | 2009-06-25 |
| Substituted methyl aryl or heteroaryl amide compounds Grant 7,534,914 - Koike , et al. May 19, 2 | 2009-05-19 |
| Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents Grant 7,479,564 - Nakao , et al. January 20, 2 | 2009-01-20 |
| Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents App 20070155732 - Nakao; Kazunari ; et al. | 2007-07-05 |
| Aryl or heteroaryl amide compounds Grant 7,238,714 - Nakao , et al. July 3, 2 | 2007-07-03 |
| Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents Grant 7,141,580 - Nakao , et al. November 28, 2 | 2006-11-28 |
| Substituted methyl aryl or heteroaryl amide compounds App 20050267170 - Koike, Hiroki ; et al. | 2005-12-01 |
| Ortho substituted aryl or heteroaryl amide compounds App 20050250818 - Koike, Hiroki ; et al. | 2005-11-10 |
| Aryl or heteroaryl amide compounds App 20050065188 - Nakao, Kazunari ; et al. | 2005-03-24 |
| Benzimidazole cyclooxygenase-2 inhibitor App 20040181062 - Okumura, Yoshiyuki ; et al. | 2004-09-16 |
| Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents App 20040181059 - Nakao, Kazunari ; et al. | 2004-09-16 |
| Benzimidazole cyclooxygenase-2 inhibitors Grant 6,713,482 - Okumura , et al. March 30, 2 | 2004-03-30 |
| Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents Grant 6,710,054 - Nakao , et al. March 23, 2 | 2004-03-23 |
| Substituted 1,4-dihydropyridine compounds as bradykinin antagonists App 20030176445 - Okumura, Yoshiyuki ; et al. | 2003-09-18 |
| Benzimidazole cyclooxygenase-2 inhibitors App 20030013886 - Okumura, Yoshiyuki ; et al. | 2003-01-16 |
| Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents App 20020107273 - Nakao, Kazunnari ; et al. | 2002-08-08 |
| Substituted 1,4-dihydropyridine compounds as bradykinin antagonists App 20020042421 - Okumura, Yoshiyuki ; et al. | 2002-04-11 |
| 5-memberd heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists App 20010046993 - Ikeda, Takafumi ; et al. | 2001-11-29 |
| 5-lipoxygenase inhibitors Grant 5,883,106 - Stevens , et al. March 16, 1 | 1999-03-16 |
| Cycloalkyl hydroxyureas Grant 5,681,858 - Stevens , et al. October 28, 1 | 1997-10-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 